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ABSTRACT We describe here a transposon-based DNA
sequencing strategy that allows the introduction of sequencing
priming sites throughout a target sequence by bacterial mating.
A miniplasmid was designed to select against transposon in-
sertions into the vector. Sites of transposon insertion are
mapped by the polymerase chain reaction with bacterial over-
night cultures providing the templates. A small set of plasmids
with transposons spaced several hundred base pairs apart can
then be sequenced. Sequencing primers corresponding to the
transposon ends allow sequencing in both directions. Thus, the
entire sequence of both strands can be easily determined.
One ofthe major problems inDNA sequence analysis oflarge
or even moderately sized fragments is how to position
unsequenced regions next to known priming sites. A variety
of techniques have been developed for this purpose including
random shotgun subcloning, unidirectional deletions and
subcloning, and the continued synthesis of additional oligo-
deoxynucleotide primers (1-4). These methods are expensive
or require many molecular manipulations.
A number of strategies employ bacterial transposons to
generate priming sites within a target DNA sequence (5-10).
Several criteria exist for an efficient transposon-based se-
quencing strategy: (i) Mobilization of the transposon must be
relatively simple. (ii) Selection for transposon insertions into
the plasmid as opposed to the bacterial chromosome must be
efficient. (iii) The transposon must insert into the target
sequence and not into the plasmid vector. (iv) The transpo-
sition sites must be easily mapped to minimize the number of
required sequencing reactions. In this paper we describe a
transposon-based strategy that meets these criteria.
We employ y6, which belongs to the Tn3 family of trans-
posons (11) and which has been used previously in transpo-
son-facilitated strategies (8, 20). The members of this family
contain 38-base-pair (bp) terminal inverted repeats and trans-
pose by a replicative mechanism. Donor and target sequences
are joined in an intermediate structure termed a cointegrate.
The cointegrate, which contains two copies of the transpo-
son, is rapidly resolved by a site-specific recombination
system. The resolvase is encoded by the transposon and acts
at the 120-bp res site located within the mobile element.
y8 is present on the F factor. Consequently, transposition
to a plasmid transiently fuses the F factor and plasmid in a
cointegrated structure. This cointegrate can be transferred to
a recipient cell by conjugation. Resolution of this structure in
the recipient yields the F factor and the plasmid each with a
single y8 insertion (Fig. 1).
This paper describes the use of conjugal transfer of a
plasmid to introduce yc insertions into a target sequence (12).
The target DNA fragment has been subcloned into a minimal
plasmid in which nearly all the plasmid sequences are select-
able. Under these conditions recovered transpositions almost
always contain a y6 transposon inserted into the target
sequences. The sites of insertion can be readily mapped by
polymerase chain reaction (PCR) (13). Finally, orientation-
specific sequencing primers allow sequence analysis in both
directions from the insertion point.
METHODS
Bacterial Mating. Two Escherichia coli strains are grown
overnight under appropriate antibiotic selection. The donor
strain, DPWC (supE42 ArecA[Sst Il-EcoRI] srl::TnJO-
[Tets], F+), contains the target plasmid, which confers resis-
tance to ampicillin. The recipient, strain JGM, is strain
MC1061 (14) that carries Tn5seql (9) and is F- and kanamy-
cin resistant. One-tenth milliliter of each overnight culture
and 2 ml of LB medium are combined in a sterile 15-ml tube
and incubated on a rotary wheel (30 rpm) for 3 hr or longer
at 370C. One-tenth milliliter of a 100-fold dilution of the
mating mixture is plated on an LB-agar plate containing both
ampicillin at 100 pug/ml and kanamycin at 50 Ag/ml. This
plate is incubated overnight at 370C. Generally, this proce-
dure yields 50-500 AmprKanr colonies. Plating nondiluted
and 10-fold dilutions ofthe mating mixture results in bacterial
lawns that consist primarily of bacteria resistant only to
kanamycin.
Construction of the Miniplasmid Vector. The miniplasmid
vector, used as a transposon target, was constructed by the
PCR (14) followed by standard recombinantDNA techniques
(15). (i) Two oligonucleotides were synthesized that would
PCR-amplify the ,8-lactamase gene and the replication origin
of the pUC plasmids. One oligonucleotide, N-AMP (5'-
ATGAGACAATAACCCTGA-3'), hybridizes just upstream
of the f-lactamase gene (near position 4210 of the pBR322
map) (16). The second oligonucleotide, ORI F (5'-
GCCCGGGCGTTGCTGGCGTTT-TlCC), is located around
pBR322 position 2520 and contains a Sma I site. A PCR was
performed by using this oligonucleotide pair as primers and
pBluescriptKS2 (Stratagene) as template. The PCR product
was phosphorylated with T4 polynucleotide kinase, ligated,
and introduced into E. coli to generate plasmid pOAS. The
polylinker from pBluescriptKS2 was then introduced into
pOAS to generate pMOB (Fig. 2). To accomplish this con-
struction, the polylinker was first PCR-amplified by using the
reverse and universal sequencing oligonucleotides that are
commercially available (New England Biolabs). Plasmid
pOAS was linearized with Sma I and ligated to the polylinker.
DNA Sequence Analysis. Templates for DNA sequence
analysis were prepared by using rapid-boil plasmid prepara-
tions (17). The sequencing reactions were done with the
United States Biochemical T7 Sequenase version 2.0 kit
according to the enclosed protocols. The sequencing primers
are oligonucleotides complementary to transposon sequences
adjacent to the inverted repeat ends. GD1 (5'-CAACGAAT-
TATCTCCTT-3') will sequence outward from the yv end
Abbreviation: PCR, polymerase chain reaction.
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FIG. 1. Transposon mobilization into target DNA sequences.
This diagrams the probable mechanism of y8-transposon insertion
into the target sequences by bacterial mating. According to this
model (5), a cointegrate is formed in the donor cell between the F
factor and the target plasmid. In this cointegrate, both plasmids are
flanked by y8transposons. Aftertransfer, the cointegrate is resolved,
leaving a transposon copy in each plasmid.
closest to the Sac I site in the transposon (12). GD2 (5'-
TCAATAAGTTATACCAT-3') will sequence outward from
the opposite end.
PCR Conditions. All PCRs were done in 40-pAl total volume
with a light mineral oil overlay. For the construction steps, a
three-step protocol was used that included the following:
94TC for 45 sec, 55TC for 45 sec, and 72TC for 2 min. This
protocol was then repeated for 10 cycles. For the transposon
mapping experiments a two-step PCR protocol was used:
92°C for 20 sec and 72°C for 2 mn. One-half microliter of a
bacterial overnight culture was added to the 40-,ul reaction
mixture and subjected to the PCR for 40 cycles. For each
template two PCRs were done. Both PCRs used an oligonu-
cleotide (GDIR; 5'-TTTCGTTCCATTGGCCCTCAAAC-
CCC-3') complementary to the inverted repeat of the y8
transposon. The second oligonucleotide primer used in one
PCR (LREV; 5'-AACAGCTATGACCATGATTACGC-
CAAG-3') was complementary to a sequence just upstream
of the T7 promoter (see Fig. 2). The second oligonucleotide
primer used in the other PCR mapping (LUNI; 5'-
GTAAAACGACGGCCAGTGAGCGCG-3') is complemen-
tary to a region immediately adjacent to the T7 RNA pro-
moter. The PCR buffer was purchased from Cetus.
RESULTS AND DISCUSSION
Efficiency of y8 Transposition into Target Plasmids. Trans-
position of 'y8 from an F factor to a plasmid is believed to
produce a cointegrate that can be conjugally transferred.
After conjugation the cointegrate is resolved in the recipient
cell (Fig. 1).
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FIG. 2. Map of pMOB, the miniplasmid used for transposon-
targeted DNA sequence analysis. This plasmid contains (i) a pUC
plasmid origin of replication (pUC ori), (ii) P-lactamase gene (Amp),(iii) a multiple cloning site (MCS), (iv) bacteriophage RNA polymer-
ase promoters (T3 and T7), (v) primer sites for PCR mapping of the
transposon insertion sites (LREV, LUNI). The polylinker was
derived from a PCR from the plasmid pBluescriptKS2; many restric-
tion sites occur in this polylinker. We have tested for and used only
the Apa I (A), EcoRl (R), Kpn I (K), Pst I (P), HindIII (H), Sac I (S)
and Xba I (Xb) sites (these sites are all unique and found only in the
MCS region). Because this plasmid was constructed from DNA
fragments amplified by PCRs, the DNA sequence may vary some-
what from sequence of the parent plasmids.
FIG. 3. PCR mapping of transposon-insertion sites. y8 trans-
posons were introduced by bacterial mating into 1.7-kb cDNA (1H2)
that was subcloned into pMOB. Bacterial overnight cultures from
each of 20 individual transposition events provided the templates in
two separate PCRs. In the first set of PCRs LREV and GDIR were
the primers; PCR products were then analyzed by agarose gel
electrophoresis (Upper, labeled LREV). The second set of PCRs
were identical, except that LUNI and GDIR oligonucleotides were
the primers (Lower); results of these PCRs are labeled LUNI. Lanes
in each ofthese gels are matched so that the upper gel shows the PCR
products generated by using the first set of primers, and the bottom
gels show the analogous products with the second set of primers.
Exact sequences of the oligonucleotides and PCR conditions are
indicated in text; interpretation of this data is presented in Fig. 4. As
mentioned in text, some PCRs gave ambiguous results: for example,
multiple PCR products can be seen in lane 9 (Lower), whereas no
apparent products can be seen in either reaction in lane 14. Size
markers (M) are Hinfl digests of pBR322.
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FIG. 4. PCR mapping analysis allows the generation of maps of the yS-transposon-insertion points. Insertions into three different cDNAs
(1H2, 1.7 kb; 1D11, 2.0 kb; and 4B9, 1.6 kb) are shown. These plasmids are all longer versions of cDNA clones originally isolated by Palazzolo
et al. (19). Each triangle represents the insertion of a single yv transposon into a given cDNA. PCR mappings that gave ambiguous results were
excluded from the map. The filled triangles represent clones selected for DNA sequence analysis. A complete double-stranded analysis was
possible from just these selected clones.
Although the mobilized plasmid is expected to contain a
single copy of yO, some experiments (18) indicated that an
alternative method of plasmid transfer is possible in certain
E. coli strains. Examination of transferred plasmids in these
strains showed that only 30% of the plasmids contained
transposons after transfer. To determine the fraction of
mobilized plasmids that contain y8, E. coli DPWC (a donor
strain; see Methods) was transformed with a 3-kilobase (kb)
plasmid vector conferring ampicillin resistance, pBlue-
scriptKS2 (Stratagene), into which a 1.5-kb Drosophila
cDNA fragment (4B9; ref. 19) had been subcloned. These
cells were then mated to JGM (a kanamycin-resistant recip-
ient strain, see Methods). Recipient cells that received the
plasmid were selected on plates containing ampicillin and
kanamycin. Restriction enzyme analysis of 20 mobilized
plasmids indicated that, in each instance, the plasmid con-
tained a y3 insertion. Furthermore, restriction fragment
length polymorphisms in the restriction enzyme digests sug-
gested that the transposons had inserted at different sites.
Construction of a Miniplasmid Sequencing Vector. An im-
portant criterion for the successful application of transposi-
tion to DNA sequence analysis is that the transposon be
forced into the target DNA sequences and not the plasmid.
Restriction analysis of the y6 insertions described above
suggested that most insertion events occurred in the vector
and not in the insert. We used dideoxynucleotide chain-
termination DNA sequencing to identify the transposon-
insertion sites in more detail. Of eight clones chosen at
random and sequenced, all transposition sites occurred at
different locations in the vector.
These experiments suggest that a plasmid, in which inser-
tions into the vector sequences can be selected against, is
useful, as then only the transposon insertions in the target can
be recovered. Ideally, the vector should contain only an
origin of replication, a drug-resistance gene, and a multiple
cloning site [the construction of such a miniplasmid, pMOB
(Fig. 2), has been described].
To test where transposons insert in this 1.8-kb construct,
three different Drosophila cDNA molecules (1H2, iD11,
4B9) (19) were subcloned into this plasmid, and each sub-
clone was separately used as target for y8 transposition.
Twenty clones from each of the mating mixtures were
selected and analyzed by restriction mapping. All 60 clones
contained a yO transposon, and most insertion sites were in
or near the target cDNA fragments.
Analysis of Transposon-Insertion Sites by PCR. The ability
to rapidly and simply map the sites of insertion is important
for minimizing the labor required to sequence a given target
DNA fragment. PCR promised to allow such an identifica-
tion. For this purpose, we synthesized three oligodeoxynu-
cleotides. One (GDIR) matches the inverted repeat found at
each end of y3. The other two oligonucleotides (LREV and
LUNI) flank the cloning site of the miniplasmid (see Fig. 2).
Two separate PCRs can be used to determine the point of
insertion of a given transposon. In one reaction LREV and
GDIR are used as primers, whereas LUNI and GDIR are
used in the second reaction. In both cases the same plasmid
containing a y5 transposon is the template. Size of the
LUNI-GDIR PCR product allows determination of the dis-
tance from the transposon-insertion site to the LUNI site at
one end of the target fragment, whereas the size of the
LREV-GDIR PCR product allows a similar determination of
the distance from transposition site to the opposite end of the
subclone. Furthermore, the two PCR products should add up
to approximately the same size as the fragment subcloned
into the miniplasmid.
Such an analysis was performed on the 60 plasmids isolated
in the transposon experiments described above. Bacterial
overnight cultures provided the templates in two separate
PCRs. These reactions were subsequently analyzed by aga-
rose gel electrophoresis. Analysis of 20 transposition events
into one clone is shown in Fig. 3. The size of the fragment in
each lane delimits the distance of the transposition site from
the fixed points in the plasmid.
These experiments allowed us to map the y5 insertion sites
for most of the 60 plasmids containing transposons (Fig. 4).
Three conclusions can be drawn from these results. (i)
Forty-two of the 60 transposition events occurred within the
cDNA inserts and could be rapidly localized. (ii) The inser-
tion sites were sufficiently dispersed within the target to be
useful for DNA sequencing. (iii) Eighteen of the PCRs gave
apparently anomalous results, including multiple PCR prod-
ucts or the apparent absence of PCR products. The transpo-
son insertions that gave such results could not be placed on
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DNA Sequence Analysis By Using Transposon Sequences as
Priming Sites. Several plasmids were then chosen for DNA
sequence analysis of the different cDNA clones. The plas-
mids that were sequenced were selected because the trans-
posons were spaced =300-400 bp apart (Fig. 4). Because
end-specific sequences are found immediately adjacent to the
inverted repeats, oligonucleotides complementary to these
regions can be used to sequence outward from each end ofthe
transposon (see Methods for primer sequences). Thus, it is
straightforward to simultaneously obtain complete sequence
information from both strands of the target sequence from a
relatively small number ofplasmid-transposon templates. All
three plasmids presented in this paper were completely
sequenced by a small number of transposon-containing tem-
plates (Fig. 4). In addition, we have sequenced six other
cDNA clones with inserts from 1.2 to 2 kb. For each clone,
a screen of 20-30 y8 insertions was sufficient to obtain a
subset of transposon insertions that were spaced every
300-400 bp along the cDNA insert.
Some Limitations to this Sequencing Strategy. One major
limitation to this strategy is the inability of the PCR to map
transpositional events that are relatively distant from the
fixed points of the plasmid (LREV and LUNI). Specifically,
PCRs typically yield anomalous products on templates in
which transposons have inserted >3 kb away from the fixed
plasmid point. One potential response to this limitation is the
use of strand-switching PCR to map the position ofunknown
transposon insertions relative to known transposon-insertion
points. In other words, two plasmids that contain the same
initial insert but have transposons in different locations can
be mapped relative to each other in a single PCR. This
reaction contains both plasmids as templates but uses only
the inverted-repeat oligonucleotide (GDIR) as primer. The
PCR product should be the DNA sequence between the two
transpositional events, and its size will map the position of
the unknown site relative to the known one.
To test this strategy we used various combinations of the
plasmids containing the 1H2 cDNA and different transposi-
tional events. PCRs containing different pairwise combina-
tions of 1H2 plasmids as templates and only GDIR as primer
resulted in PCR products of the sizes predicted by the results
presented in Figs. 3 and 4.
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